Test Bank for Clayton’s Basic Pharmacology for Nurses, 29th Edition by Michelle J. Willihnganz.pdf

TestBBankBForBClayton’sBBasicBPharmacologyBforBNursesB19thBEditio 1
n



COMPELETE TESTBANK B




TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY F
B B B B B


OR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIED Q
B B B B B B


UESTIONS AND ANSWERS WITH 2024 UPDATES (ALL C
B B B B B B B


HAPTERS INLUDED 1-48) B B

,TestBBankBForBClayton’sBBasicBPharmacologyBforBNursesB19thBEditio 2
n




Chapter 01: Drug Definitions, Standards, and Information Sources Willihngan
B B B B B B B B

z: Clayton’s Basic Pharmacology for Nurses, 19th Edition
B B B B B B B




1. WhichBnameBidentifiesBaBdrugBlistedBbyBtheBUSBFoodBDru
gBAdministrationB(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
TheBofficialBnameBisBtheBnameBunderBwhichBaBdrugBisBlistedBbyB
theBFDA.BTheBbrandBname,BorBtrademark,BisBtheBnameBgivenBto
BaBdrugBbyBitsBmanufacturer.BTheBnonproprietary, BorBgeneric,Bn

ameBisBprovidedBbyBtheBUnitedBStatesBAdoptedBNamesBCouncil
.
CognitiveBLevel:BKnowledge REF:B p.B9
OBJ:B1NAT:BNCLEXBClientBNeedsBCategory:BSafe,BEffectiveBCar
eBEnvironmentBTOP:B NursingBProcessBStep:BAssessment
CON:B
PatientBEducation




2. WhichBsourceBcontainsBinformationBspecificBtoBnutritionalBsupplements?
a. USPBDictionaryBofBUSANB &BInternationalBDrugBNames
b. NaturalBMedicinesBComprehensiveBDatabase
c. UnitedBStatesBPharmacopoeia/NationalBFormularyB(USPBNF)
d. DrugBInteractionBFacts
ANS:BC
UnitedBStatesBPharmacopoeia/NationalBFormularyBcontainsBinformationBspecificBtoBnutritionalBsup
plements.BUSPBDictionaryBofBUSANB&BInternationalBDrugBNamesBisBaBcompilationBofBdrugBnames,
BpronunciationBguide,BandBpossibleBfutureBFDABapprovedBdrugs;BitBdoesBnotBincludeBnutritionalBsu

pplements.BNaturalBMedicinesBComprehensiveBDatabaseBcontains
evidence-
basedBinformationBonBherbalBmedicinesBandBherbalBcombinationBproducts;BitBdoesBnotBincludeBi
nformationBspecificBtoBnutritionalBsupplements.BDrugBInteractionBFactsBcontainsBcomprehensi
veBinformationBonBdrugBinteractionBfacts;BitBdoesBnotBincludeBnutritionalBsupplements.

DIF: CognitiveBLevel:BKnowledge REF:B p.B4
OBJ:B3BNAT:B NCLEXBClientBNeedsBCategory:BPhysiologicalBInte
grity
TOP:B NursingBProcessBStep:BAssessment CON:B NutritionB|BPatientBEducation

3. WhichBdrugBreferenceBcontainsBdrugBmonographsBthatBdescribeBallBdrugsBinBaBtherapeuticBclass?
a. DrugBFactsBandBComparisons

,TestBBankBForBClayton’sBBasicBPharmacologyBforBNursesB19thBEditio 3
n
b. DrugBInteractionBFacts
c. HandbookBonBInjectableBDrugs
d. Martindale—TheBCompleteBDrugBReference

ANS:BA
DrugBFactsBandBComparisonsBcontainsBdrugBmonographsBthatBdescribeBallBdrugsBinBaB
therapeuticBclass.BMonographsBareBformattedBasBtablesBtoBallowBcomparisonBofBsimilarB
products,BbrandBnames,Bmanufacturers,BcostBindices,BandBavailableBdosageBformsBOnli
neBversionBisBavailable.

DIF: CognitiveBLevel:BKnowledge REF:B p.B4BTableB1.2
OBJ:B B 3 NAT:B NCLEXBClientBNeedsBCategory:BPhysiologicalBIntegrity
TOP:B NursingBProcessBStep:BAssessment CON:B SafetyB|BPatientBEducationB|BClinicalBJudgment

4. WhichBdrugBreferenceBcontainsBmonographsBaboutBvirtuallyBeveryBsingle-
entityBdrugBavailableBinBtheBUnitedBStatesBandBdescribesBtherapeuticBusesBofBdrugs,Bincluding
BapprovedBandBunapprovedBuses?

a. Martindale:BTheBCompleteBDrugBReference
b. AHFSBDrugBInformation
c. DrugBReference
d. DrugBFactsBandBComparisons
ANS:BB
AHFSBDrugBInformationBcontainsBmonographsBaboutBvirtuallyBeveryBsingle-
entityBdrugBavailableBinBtheBUnitedBStatesBandBdescribesBtherapeuticBusesBofBdrugs,BincludingBa
pprovedBandBunapprovedBuses.

DIF: CognitiveBLevel:BKnowledge REF:B p.B4BTableB1.2
OBJ:B B 3 NAT:B NCLEXBClientBNeedsBCategory:BPhysiologicalBIntegrity
TOP:B NursingBProcessBStep:BPlanning CON:B SafetyB|BPatientBEducationB|BClinicalBJudgment

5. WhichBonlineBdrugBreferenceBmakesBavailableBtoBhealthcareBprovidersBandBtheBpublicBaBsta
ndard,Bcomprehensive,Bup-to-dateBlookBupBandBdownloadableBresourceBaboutBmedicines?
a. AmericanBDrugBIndex
b. AmericanBHospitalBFormulary
c. DailyMed
d. DrugBReference
ANS:BC
DailyMedBmakesBavailableBtoBhealthcareBprovidersBandBtheBpublicBaBstandard,Bcomprehensive
,Bup-to-
dateBlookBupBandBdownloadableBresourceBaboutBmedicines.BTheBAmericanBDrugBIndexBisBnotBa
ppropriateBforBpatientBuse.BTheBAmericanBHospitalBFormularyBisBnotBappropriateBforBpatientB
use.BTheBdrugBreferenceBisBnotBappropriateBforBpatientBuse.

DIF: CognitiveBLevel:BKnowledge REF:B p.B3B|Bp.B4
OBJ:B3BNAT:B NCLEXBClientBNeedsBCategory:BPhysiologicalBInte
grity
TOP:B NursingBProcessBStep:BImplementation
CON:B SafetyB|BPatientBEducationB|BClinicalBJudgment

6. WhichBlegislationBauthorizesBtheBFDABtoBdetermineBtheBsafetyBofBaBdrugBbeforeBitsBmarketing?
a. FederalBFood,BDrug,BandBCosmeticBActB(1938)
b. DurhamBHumphreyBAmendmentB(1952)

, TestBBankBForBClayton’sBBasicBPharmacologyBforBNursesB19thBEditio 4
n
c. ControlledBSubstancesBActB(1970)
d. KefauverBHarrisBDrugBAmendmentB(1962)
ANS:BA
TheBFederalBFood,BDrug,BandBCosmeticBActBofB1938BauthorizedBtheBFDABtoBdetermineBtheBsaf
etyBofBallBdrugsBbeforeBmarketing.BLaterBamendmentsBandBactsBhelpedBtightenBFDABcontrolBan
dBensureBdrugBsafety.BTheBDurhamBHumphreyBAmendmentBdefinesBtheBkindsBofBdrugsBthatBca
nnotBbeBusedBsafelyBwithoutBmedicalBsupervisionBandBrestrictsBtheirBsaleBtoBprescriptionBbyBaBli
censedBpractitioner.BTheBControlledBSubstancesBActBaddressesBonlyBcontrolledBsubstancesBandBt
heirBcategorization.BTheBKefauverBHarrisBDrugBAmendmentBensuresBdrugBefficacyBandBgreaterB
drugBsafety.BDrugBmanufacturersBareBrequiredBtoBproveBtoBtheBFDABtheBeffectivenessBofBtheirB
productsBbeforeBmarketingBthem.

DIF: CognitiveBLevel:BKnowledge REF:B p.B5BTableBl.3
OBJ:B 5
NAT:BNCLEXBClientBNeedsBCategory:BPhysiologicalBIntegrit
yBTOP:B NursingBProcessBStep:BAssessment
CON:B SafetyB|BPatientBEducationB|BEvidenceB|BHealthBCareBLaw

7. WhichBclassificationBdoesBmeperidineB(Demerol)BfallBunder?
a. I
b. II
c. III
d. IV
ANS:BB
MeperidineB(Demerol)BisBaBScheduleBIIBdrug;BitBhasBaBhighBpotentialBforBabuseBandBmayBleadBt
oBsevereBpsychologicalBandBphysicalBdependence.BScheduleBIBdrugsBhaveBhighBpotentialBforBab
useBandBnoBrecognizedBmedicalBuse.BScheduleBIIIBdrugsBhaveBsomeBpotentialBforBabuse.BUseB
mayBleadBtoBlowBtoBmoderateBphysicalBdependenceBorBhighBpsychologicalBdependence.BSched
uleBIVBdrugsBhaveBlowBpotentialBforBabuse.BUseBmayBleadBtoBlimitedBphysicalBorBpsychologica
lBdependence.

DIF: CognitiveBLevel:BKnowledge REF:B p.B10
OBJ:B2BNAT:B NCLEXBClientBNeedsBCategory:BSafe,BEffectiveBCa
reBEnvironment
TOP:B NursingBProcessBStep:BAssessment CON:B PatientBEducationB|BAddictionB|BPain

8. WhichBactionBwouldBtheBFDABtakeBtoBexpediteBdrugBdevelopmentBandBapprovalBforBanBoutbrea
kBofBsmallpox?
a. ListBsmallpoxBasBaBhealthBorphanBdisease.
b. OmitBtheBpreclinicalBresearchBphase.
c. ExtendBtheBclinicalBresearchBphase.
d. FastBtrackBtheBinvestigationalBdrug.
ANS:BD
OnceBtheBInvestigationalBNewBDrugBApplicationBhasBbeenBapproved,BtheBdrugBcanBreceiveBhig
hestBpriorityBwithinBtheBagency,BwhichBisBcalledBfastBtracking.BABsmallpoxBoutbreakBwouldBbe
comeBaBpriorityBconcernBinBtheBworld.BOrphanBdiseasesBareBnotBresearchedBinBaBpriorityBmanne
r.BPreclinicalBresearchBisBnotBomitted.BExtendingBanyBphaseBofBtheBresearchBwouldBmeanBaBlon
gerBtimeBtoBdevelopBaBvaccine.BTheBFDABmustBensureBthatBallBphasesBofBtheBpreclinicalBandBclin
icalBresearchBphaseBhaveBbeenBcompletedBinBaBsafeBmanner.

DIF: CognitiveBLevel:BKnowledge REF:B p.B7 OBJ:B 5